Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
PI3Kα inhibition reduces obesity in mice.
Lopez-Guadamillas E, Muñoz-Martin M, Martinez S, Pastor J, Fernandez-Marcos PJ, Serrano M. Lopez-Guadamillas E, et al. Aging (Albany NY). 2016 Nov 4;8(11):2747-2753. doi: 10.18632/aging.101075. Aging (Albany NY). 2016. PMID: 27816049 Free PMC article.
Inactivation of the candidate tumor suppressor par-4 in endometrial cancer.
Moreno-Bueno G, Fernandez-Marcos PJ, Collado M, Tendero MJ, Rodriguez-Pinilla SM, Garcia-Cao I, Hardisson D, Diaz-Meco MT, Moscat J, Serrano M, Palacios J. Moreno-Bueno G, et al. Cancer Res. 2007 Mar 1;67(5):1927-34. doi: 10.1158/0008-5472.CAN-06-2687. Cancer Res. 2007. PMID: 17332319
Telomerase reverse transcriptase delays aging in cancer-resistant mice.
Tomás-Loba A, Flores I, Fernández-Marcos PJ, Cayuela ML, Maraver A, Tejera A, Borrás C, Matheu A, Klatt P, Flores JM, Viña J, Serrano M, Blasco MA. Tomás-Loba A, et al. Cell. 2008 Nov 14;135(4):609-22. doi: 10.1016/j.cell.2008.09.034. Cell. 2008. PMID: 19013273 Free article.
Simultaneous inactivation of Par-4 and PTEN in vivo leads to synergistic NF-kappaB activation and invasive prostate carcinoma.
Fernandez-Marcos PJ, Abu-Baker S, Joshi J, Galvez A, Castilla EA, Cañamero M, Collado M, Saez C, Moreno-Bueno G, Palacios J, Leitges M, Serrano M, Moscat J, Diaz-Meco MT. Fernandez-Marcos PJ, et al. Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12962-7. doi: 10.1073/pnas.0813055106. Epub 2009 May 26. Proc Natl Acad Sci U S A. 2009. PMID: 19470463 Free PMC article.
Therapeutic effect of γ-secretase inhibition in KrasG12V-driven non-small cell lung carcinoma by derepression of DUSP1 and inhibition of ERK.
Maraver A, Fernández-Marcos PJ, Herranz D, Muñoz-Martin M, Gomez-Lopez G, Cañamero M, Mulero F, Megías D, Sanchez-Carbayo M, Shen J, Sanchez-Cespedes M, Palomero T, Ferrando A, Serrano M. Maraver A, et al. Cancer Cell. 2012 Aug 14;22(2):222-34. doi: 10.1016/j.ccr.2012.06.014. Cancer Cell. 2012. PMID: 22897852 Free PMC article.
Sirt4: the glutamine gatekeeper.
Fernandez-Marcos PJ, Serrano M. Fernandez-Marcos PJ, et al. Cancer Cell. 2013 Apr 15;23(4):427-8. doi: 10.1016/j.ccr.2013.04.003. Cancer Cell. 2013. PMID: 23597559 Free PMC article.
NOTCH pathway inactivation promotes bladder cancer progression.
Maraver A, Fernandez-Marcos PJ, Cash TP, Mendez-Pertuz M, Dueñas M, Maietta P, Martinelli P, Muñoz-Martin M, Martínez-Fernández M, Cañamero M, Roncador G, Martinez-Torrecuadrada JL, Grivas D, de la Pompa JL, Valencia A, Paramio JM, Real FX, Serrano M. Maraver A, et al. J Clin Invest. 2015 Feb;125(2):824-30. doi: 10.1172/JCI78185. Epub 2015 Jan 9. J Clin Invest. 2015. PMID: 25574842 Free PMC article. Clinical Trial.
Bladder cancer and the Notch pathway.
Fernandez-Marcos PJ, Serrano M, Maraver A. Fernandez-Marcos PJ, et al. Oncotarget. 2015 Jan 30;6(3):1346-7. doi: 10.18632/oncotarget.3183. Oncotarget. 2015. PMID: 25633811 Free PMC article. No abstract available.
53 results